Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

ClinicalTrials.gov 24,857 recruiting now free trial finder

Find a clinical trial that's recruiting now

Search 24,857 actively recruiting US clinical trials by condition, drug, or state, each entry links straight to its NIH ClinicalTrials.gov record so you can check eligibility and contact the study team.

24,857
trials recruiting now
14%
of all US trials open to enrollment
52
states with recruiting sites

A trial is listed as recruiting when its sponsor has marked it open to new participants on the public registry. Type a condition or drug name (for example, "breast cancer" or "pembrolizumab") to narrow the list, and add a state to find studies with a site near you. Results are ordered with the most relevant recruiting studies first; each card shows the study phase and enrollment target, and opens the full record, including eligibility criteria and contact details, on ClinicalTrials.gov.

100 trials found

Recruiting 5,000,000 target

The Pediatric Anesthesia Quality Improvement Project

The Society for Pediatric Anesthesia

NCT00674388

Recruiting 999,999 target

Molecular Genetics Studies of Cancer Patients and Their Relatives

City of Hope Medical Center

NCT04185935

Recruiting 999,999 target

Integrated Cancer Repository for Cancer Research

University of Nebraska

NCT02012699

Recruiting 80,000 target

Generic Database of Very Low Birth Weight Infants

NICHD Neonatal Research Network

NCT00063063

Recruiting 68,000 target

Follow-up Visit of High Risk Infants

NICHD Neonatal Research Network

NCT00009633

Recruiting 40,000 target

Stroke Thrombectomy and Aneurysm Registry

Medical University of South Carolina

NCT04994756

Recruiting 14,000 target

Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes

Baylor Research Institute

NCT01904851

Recruiting NA 8,100 target

Behavioral Economic & Staffing Strategies in the ICU

University of Nebraska

NCT06184945

Recruiting 8,000 target

Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY

Massachusetts General Hospital

NCT04916210

Recruiting NA 8,000 target

Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women

M.D. Anderson Cancer Center

NCT00539162

Recruiting Phase 4 7,410 target

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

VA Office of Research and Development

NCT02915198

Recruiting 7,000 target

Quality of Pediatric Resuscitation in a Multicenter Collaborative

Children's Hospital of Philadelphia

NCT02708134

Recruiting Phase 3 6,000 target

BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies

Pfizer

NCT07160244

Recruiting 5,000 target

Middle Meningeal Artery Embolization (MMAE) Outcomes for Chronic Subdural Hematoma (cSDH)

Montefiore Medical Center

NCT06181994

Recruiting 5,000 target

Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others

Michael Shy

NCT01193075

Recruiting 5,000 target

Collection of Tissue Samples for Cancer Research

National Cancer Institute (NCI)

NCT00900198

Recruiting 5,000 target

TSC Biosample Repository and Natural History Database

National Tuberous Sclerosis Association

NCT05676099

Recruiting 5,000 target

Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset

The University of Texas Health Science Center, Houston

NCT05685745

Recruiting 5,000 target

The Society for Obstetric Anesthesia and Perinatology Research Network General Anesthesia Registry

Yale University

NCT06030063

Recruiting 5,000 target

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

Duke University

NCT04278404

Recruiting 5,000 target

CureDuchenne Link®: A Resource for Research

CureDuchenne

NCT04972604

Recruiting NA 4,000 target

The Fourth Left Atrial Appendage Occlusion Study

Hamilton Health Sciences Corporation

NCT05963698

Recruiting 4,000 target

American Lung Association (ALA) Lung Health Cohort

Johns Hopkins University

NCT04543461

Recruiting 3,500 target

Genetic Epidemiology of Rotator Cuff Tears: The cuffGEN Study

University of Michigan

NCT04831164

Recruiting NA 3,218 target

Rigorous Evaluation of the READY to Stand Curriculum to Prevent the Commercial Sexual Exploitation of Children

University of Michigan

NCT06587529

Recruiting NA 3,090 target

The ED-AWARENESS-2 Trial

Washington University School of Medicine

NCT05534243

Recruiting 3,000 target

Pulmonary Hypertension Association Registry

Pulmonary Hypertension Association

NCT04071327

Recruiting 3,000 target

Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study

Friedreich's Ataxia Research Alliance

NCT06016946

Recruiting NA 2,634 target

RESTORE: REducing Future fractureS and Improving ouTcOmes of fRagility fracturE

University of Alabama at Birmingham

NCT06455085

Recruiting 2,600 target

The Heartland Study

Heartland Health Research Alliance

NCT05492708

Recruiting Phase 3 2,540 target

CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes

VA Office of Research and Development

NCT05931276

Recruiting 2,500 target

MOON Shoulder Instability-Cohort of Patients Undergoing Operative Treatment.

Carolyn M Hettrich

NCT02075775

Recruiting NA 2,433 target

Neonatal Platelet Transfusion Threshold Trial

NICHD Neonatal Research Network

NCT06676904

Recruiting NA 2,300 target

Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women

Weill Medical College of Cornell University

NCT04124120

Recruiting 2,062 target

Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors

SWOG Cancer Research Network

NCT04871542

Recruiting NA 2,039 target

Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiography SuiTe

Santiago Ortega Gutierrez

NCT06825897

Recruiting 2,000 target

Aquagenic Wrinkling Prediction

University of Iowa

NCT06831110

Recruiting 2,000 target

ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome

Stanford University

NCT02848274

Recruiting 2,000 target

Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy

Sequenom

NCT01429389

Recruiting Phase 3 1,800 target

Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep (MINDDS II)

Massachusetts General Hospital

NCT06192615

Recruiting 1,650 target

Prospective Study to Assess a Diagnostic Aid for Cancer

Harbinger Health

NCT07046260

Recruiting 1,600 target

Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

Duke University

NCT03511118

Recruiting 1,600 target

Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study

M.D. Anderson Cancer Center

NCT06651580

Recruiting NA 1,600 target

StrokeNet Thrombectomy Endovascular Platform

Medical University of South Carolina

NCT06289985

Recruiting 1,600 target

A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)

Bristol-Myers Squibb

NCT05489705

Recruiting Phase 3 1,590 target

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

Janssen Research & Development

NCT05552222

Recruiting NA 1,530 target

Optimal Ventilation for Cardiac Arrest

Children's Hospital of Philadelphia

NCT07114510

Recruiting 1,500 target

ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)

Alnylam Pharmaceuticals

NCT04561518

Recruiting NA 1,500 target

Rigorous Evaluation of Let's Talk Birth Control

Child Trends

NCT06670066

Recruiting Phase 2 1,500 target

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

Sparrow Pharmaceuticals

NCT07296484

Recruiting Phase 1 1,405 target

Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age

ModernaTX

NCT05992935

Recruiting NA 1,400 target

Dime La VerDAD: Verify, Debunk, and Disseminate

University of Chicago

NCT06417762

Recruiting Phase 3 1,310 target

Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

Merck Sharp & Dohme

NCT06136624

Recruiting Phase 2 1,260 target

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

BioNTech SE

NCT06712316

Recruiting 1,250 target

The Effects of the CF Carrier State on the Kidneys and Pancreas

Philip Polgreen

NCT05474417

Recruiting 1,200 target

GEMINI-NSCLC: NSCLC Biomarker Study

Tempus AI

NCT05236114

Recruiting Phase 3 1,200 target

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

Merck Sharp & Dohme

NCT06136559

Recruiting Phase 3 1,095 target

Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma

Genmab

NCT06191744

Recruiting 1,050 target

Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2

University of Iowa

NCT01193088

Recruiting 1,000 target

Beat Childhood Cancer Specimen Banking and Data Registry

Giselle Sholler

NCT04715178

Recruiting 1,000 target

University of Iowa Interventional Psychiatry Service Patient Registry

Mark Niciu

NCT04480918

Recruiting 1,000 target

Mitral Valve Screening Survey

Medstar Health Research Institute

NCT04736667

Recruiting Phase 3 1,000 target

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

Eli Lilly and Company

NCT07412756

Recruiting Phase 3 1,000 target

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

Olema Pharmaceuticals

NCT07085767

Recruiting 1,000 target

SPIROMICS Study of Early COPD Progression (SOURCE)

University of Massachusetts, Worcester

NCT05033990

Recruiting NA 1,000 target

A Randomized Comparison of Personalized Therapy Mgmt Based On Coronary Atherosclerotic Plaque Vs. Usual Care for Symptomatic Patients With Suspicion of CAD

Cleerly

NCT06713239

Recruiting Phase 2 990 target

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Bristol-Myers Squibb

NCT07221357

Recruiting Phase 3 970 target

Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)

Direct Biologics

NCT05354141

Recruiting Phase 2 956 target

Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)

BicycleTx Limited

NCT06225596

Recruiting Phase 1 949 target

A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors

Bristol-Myers Squibb

NCT04895709

Recruiting Phase 3 940 target

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

Novartis Pharmaceuticals

NCT06855277

Recruiting Phase 1 933 target

A Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With Cemiplimab for Adult Participants With Advanced Cancers

Regeneron Pharmaceuticals

NCT04626635

Recruiting NA 930 target

SMBP Study: Improving High Blood Pressure in Older Adults With Multiple Chronic Diseases

Korey Kennelty

NCT06932029

Recruiting 900 target

A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA

Ascendis Pharma Endocrinology Division A/S

NCT05820672

Recruiting Phase 2 900 target

Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

SWOG Cancer Research Network

NCT06769126

Recruiting NA 900 target

Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP)

University of Michigan

NCT05376267

Recruiting Phase 3 868 target

A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)

Merck Sharp & Dohme

NCT06077760

Recruiting Phase 3 864 target

A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma

GlaxoSmithKline

NCT06256588

Recruiting Phase 2 854 target

A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

AbbVie

NCT07005102

Recruiting NA 850 target

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

Abbott Medical Devices

NCT06526195

Recruiting 850 target

JUPITER 4.0 - Risk Factors for Failure of Isolated Medial Patellofemoral Ligament Reconstruction

Hospital for Special Surgery, New York

NCT06883396

Recruiting Phase 3 830 target

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

AstraZeneca

NCT06868277

Recruiting Phase 3 800 target

Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab

TG Therapeutics

NCT05877963

Recruiting 800 target

Pregnancy 24/7 Offspring Study

Kara Whitaker

NCT07172880

Recruiting Phase 3 795 target

A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide

Janssen Research & Development

NCT06208150

Recruiting Phase 3 780 target

A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma

BeiGene

NCT05100862

Recruiting Phase 3 770 target

Multi-Center Clean Air Randomized Controlled Trial in COPD

JHSPH Center for Clinical Trials

NCT06376994

Recruiting Phase 1 768 target

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Boehringer Ingelheim

NCT06324357

Recruiting NA 768 target

Video Telehealth Pulmonary Rehabilitation to Reduce Hospital Readmission in Chronic Obstructive Pulmonary Disease

University of Alabama at Birmingham

NCT05119556

Recruiting Phase 2 744 target

Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production Cells

Bavarian Nordic

NCT07199569

Recruiting Phase 4 730 target

Oxytocin and Fetal Heart Rate Changes

Unyime Ituk

NCT03232918

Recruiting Phase 4 730 target

Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study

Chris Goss

NCT05548283

Recruiting Phase 1 720 target

First-in-Human Study of STX-478 as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Eli Lilly and Company

NCT05768139

Recruiting Phase 1 714 target

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

Seagen, a wholly owned subsidiary of Pfizer

NCT05208762

Recruiting 700 target

Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)

Virginia Commonwealth University

NCT03981575

Recruiting 700 target

Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)

Novartis Pharmaceuticals

NCT04174157

Recruiting NA 700 target

ELEVATE-HFpEF Clinical Study

Medtronic Cardiac Rhythm and Heart Failure

NCT06678841

Recruiting NA 699 target

A Global Study Comparing Pulsed Field Ablation With Electrographic Flow Mapping Versus Posterior Wall Ablation for Persistent Atrial Fibrillation

Boston Scientific Corporation

NCT07187115

Recruiting Phase 2 690 target

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

Bristol-Myers Squibb

NCT07221149

Recruiting 680 target

A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa

argenx

NCT06298565

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Recruiting status is reported by each study's sponsor and mirrored from the public registry. Always confirm current eligibility and status on ClinicalTrials.gov before contacting a study.

Verify with NIH →